| 1 |
34624444 | An optimally designed anti-human CD40 antibody with potent B cell suppression for the treatment of autoimmune diseases. | 2021 Nov 20 |
1 |
| 2 |
30902820 | Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study. | 2019 Jun |
2 |
| 3 |
29127458 | Safety, pharmacokinetics and pharmacodynamics of single rising doses of BI 655064, an antagonistic anti-CD40 antibody in healthy subjects: a potential novel treatment for autoimmune diseases. | 2018 Feb |
2 |
| 4 |
30113724 | Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 655064, an Antagonistic Anti-CD40 Antibody, in Healthy Subjects: A Potential Novel Treatment for Autoimmune Diseases. | 2018 Dec |
1 |